Safety and technique of ferumoxytol administration for MRI
Magnetic Resonance in Medicine2016Vol. 75(5), pp. 2107–2111
Citations Over TimeTop 1% of 2016 papers
Shreyas Vasanawala, Kim‐Lien Nguyen, Michael D. Hope, Mellena D. Bridges, Thomas A. Hope, Scott B. Reeder, Mustafa R. Bashir
Abstract
Ferumoxytol is an ultrasmall superparamagnetic iron oxide agent marketed for the treatment of anemia. There has been increasing interest in its properties as an MRI contrast agent as well as greater awareness of its adverse event profile. This mini-review summarizes the current state of knowledge of the risks of ferumoxytol and methods of administration.
Related Papers
- → Safety and technique of ferumoxytol administration for MRI(2016)202 cited
- → A pilot investigation of new superparamagnetic iron oxide (ferumoxytol) as a contrast agent for cardiovascular MRI(2003)74 cited
- → Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific(2016)47 cited
- → Parenteral ferumoxytol interaction with magnetic resonance imaging: a case report, review of the literature and advisory warning(2013)20 cited
- → In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium‐based contrast agent(2013)2 cited